Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07281092 · ClinicalTrials.gov registry record · NA

Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)

A NA study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Seattle Children's Hospital.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
2
Study locations

NCT07281092: Recruiting NA study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Seattle Children's Hospital.

NCT07281092 is a NA study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 36 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07281092, a NA study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, is actively recruiting participants, sponsored by Seattle Children's Hospital.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Primary Outcome

Measured using the Conners 3 self and parent reports from the pre- and post- treatment questionnaires. Participants will rate several statements using a scale ranging from 0 to 3 (from Not True at All to Very Much True). Higher scores indicate more behavioral, emotional, or ADHD-related concerns.

Interventions

  • BEHAVIORAL Mindfulness-Based Intervention
  • BEHAVIORAL Organizational Skills Training

Study Locations (2)

Washington

  • Seattle Children's Hospital - Seattle
  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-10-01
Est. Completion 2026-08-01
Phase NA
Seattle Children's Hospital

168 total trials

What NCT07281092 shows while recruiting

NCT07281092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Intervention is the first listed.

NCT07281092 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT07281092 about?

NCT07281092 is a clinical study titled "Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)". This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-tr...

What is the current status of trial NCT07281092?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-10-01. Estimated completion is 2026-08-01.

What conditions does trial NCT07281092 study?

This clinical trial studies the following conditions: ADHD, ADHD - Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT07281092?

The interventions under investigation include: Mindfulness-Based Intervention (BEHAVIORAL), Organizational Skills Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07281092?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07281092 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07281092's enrollment target sits among peer trials

36 55th of 75 higher than 18 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07281092, the US trial registry maintained by the National Library of Medicine. NCT07281092 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.